RCM
CMRAW

Rivernorth Capital Management’s Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 CMRAW Stock Holding History

Rivernorth Capital Management’s Portfolio CMRAW Stock Details CMRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-74,999
Closed -$225 – 520
2023
Q4 		$225 Hold
74,999
– – ﹤0.01% 484
2023
Q3 		$1.63K Hold
74,999
– – ﹤0.01% 506
2023
Q2 		$2.03K Hold
74,999
– – ﹤0.01% 522
2023
Q1 		$3.23K Hold
74,999
– – ﹤0.01% 567
2022
Q4 		$3.75K Hold
74,999
– – ﹤0.01% 622
2022
Q3 		$5K Hold
74,999
– – ﹤0.01% 750
2022
Q2 		$11K Buy
+74,999
New +$12.3K ﹤0.01% 655

Rivernorth Capital Management's CMRAW Position: Q1 2024 in Review

Rivernorth Capital Management sold out of Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 (CMRAW) in Q1 2024, closing a stake of 74,999 shares — an estimated $225 sold.

Rivernorth Capital Management first reported a position in CMRAW in Q2 2022 and held it in 7 quarters. The position peaked at $11K in Q2 2022. 0 funds tracked by Wall St. Rank hold CMRAW as of Q1 2024.

  • Rivernorth Capital Management reported no remaining Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 position as of Q1 2024 after selling out during the quarter.
  • Rivernorth Capital Management sold 74,999 Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 shares in Q1 2024, an estimated $225.
  • Rivernorth Capital Management first reported a position in Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 in Q2 2022 and held it in 7 quarters.
  • Rivernorth Capital Management's Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 position peaked at $11K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 as of Q1 2024.

Based on Rivernorth Capital Management's 13F filing for Q1 2024, filed 15 May 2024.